Former Senate leader Tom Daschle has been tapped by President-Elect Barack Obama as the new Secretary of Health and Human Services. Here is some of the legislation Senator Dashcle either sponsored or co-sponsored related to FDA and to the pharmaceutical industry that provides some insight into positions. Perhaps most noteworthy is the FAIR Act:
- S.2328 - Pharmaceutical Market Access and Drug Safety Act of 2004 - A bill that would amend FDA to allow the importation of drugs. It would have required manufacturers to submit a statement that explained the differences between approved drugs for the US and a related drug from a foreign country. (co-sponsor)
- S.2486 - Fair Advertising and Increased Research Act (FAIR) - A bill that would limit the deduction for advertisting of FDA approved prescription drugs by the manufacturer of such drugs to the level of such manufacturer's research and development expenditures. (co-sponsor)
- S.1638 - Healthy Kids Act - A bill that would help parents keep their children from starting tobacco use and to stop the tobacco industry to stop targeting children and to reduce overall use of tobacco.
- S.1976 - National Cancer Act of 2002 - This bill was aimed to fund prevention and treatment programs of the NCI, including translational cancer research and addresses issues including clinical trial participation; workforce needs; Medicare coverage; protocols and guidelines; National Program of Comprehensive Cancer Control Plans; the supply of researchers; environmental risk factors research; and colorectal cancer screening demonstration program.
Comments